Skip to main content
. 2019 Apr 3;19(6):4569–4578. doi: 10.3892/mmr.2019.10120

Figure 5.

Figure 5.

Intimal hyperplasia in different G-CSF treatment groups. (A) Control group (NS 0.5 ml/kg/day), (B) the low dosage group (G-CSF 2.5 mg/kg/day), (C) medium dosage group (G-CSF 5 mg/kg/day) and (D) high dosage group (G-CSF 10 mg/kg/day) (hematoxylin and eosin stain; magnification, ×40). G-CSF, granulocyte colony-stimulating factor; NS, ameroid constrictor group receiving saline; Con, control.